SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001785530-24-000028
Filing Date
2024-08-08
Accepted
2024-08-08 07:12:14
Documents
67
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q howl-20240630.htm   iXBRL 10-Q 1469200
2 EX-4.1 a6302024ex41.htm EX-4.1 69036
3 EX-10.1 a06302024ex101.htm EX-10.1 397147
4 EX-31.1 a06302024ex311.htm EX-31.1 10336
5 EX-31.2 a06302024ex312.htm EX-31.2 10360
6 EX-32.1 a06302024ex321.htm EX-32.1 7039
  Complete submission text file 0001785530-24-000028.txt   6440336

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT howl-20240630.xsd EX-101.SCH 37753
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT howl-20240630_cal.xml EX-101.CAL 52673
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT howl-20240630_def.xml EX-101.DEF 194933
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT howl-20240630_lab.xml EX-101.LAB 459648
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT howl-20240630_pre.xml EX-101.PRE 346773
69 EXTRACTED XBRL INSTANCE DOCUMENT howl-20240630_htm.xml XML 637723
Mailing Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 200 TALCOTT AVENUE 2ND FLOOR WATERTOWN MA 02472 617-952-0555
Werewolf Therapeutics, Inc. (Filer) CIK: 0001785530 (see all company filings)

IRS No.: 823523180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40366 | Film No.: 241186013
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)